Pfizer PFE and BioNTech BNTX announced that they are planning to test a three-dose regimen of their COVID-19 vaccine, Comirnaty (BNT162b), in children aged six months to five years, following routine ...
Many oral drugs show a high variability in pharmacokinetic exposure, and, for drugs with exposure related to efficacy, therapeutic drug monitoring can help optimize exposure in individual patients.
Pfizer and BioNTech are testing a third dose of their Covid-19 vaccine in an ongoing trial of children ages 6 months to under 5 years after the companies found that the two-dose regimen didn’t ...
(AP) – A real-world test of Pfizer’s COVID-19 vaccine in more than half a million people confirms that it’s very effective at preventing serious illness or death, even after one dose. Wednesday’s ...
Factors predicting favorable outcome following autologous stem cell transplantation for primary refractory or relapsed Hodgkin’s disease: A prognostic model based on 20 year follow up ...
Low-dose CT scan helps detect lung cancer early, improving survival. Learn who needs LDCT screening, its benefits, risks and how it saves lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results